- In December 2021, Roche has launched the AVENIO Edge System to simplify and automate NGS sample preparation, reducing human error and enhancing precision medicine. This fully-integrated, automated solution will strengthen Roche's sequencing technologies, improving efficiency and supporting their growth in the precision medicine market
- In November 2021, Illumina Inc., announced a partnership with Sequoia Capital China to establish first start-ups to join Genomics Incubator in China. This will increase the company’s research and development plans towards Genomics and has supported the company to establish genomics library in China
- In October 2021, ThermoFisher Scientific Inc. announced that it has launched Applied Biosystem QuantSudio Absolute Q-Digital PCR System, which is a designed to provide highly accurate results in genetic analysis. The digital PCR is already in use for monitoring cancer driven mutations in liquid biopsy. This has helped he company to increase its product portfolio
- In September 2021, ThermoFisher Scientific Inc. announced that it has entered into partnership with AstraZeneca to develop NGS-based companion diagnostics. The NGS workflow includes multiple solutions for liquid biopsy testing and solid tumor biomarkers. This is expected to expand the company’s product portfolio
- In August 2021, Illumina Inc. announced that it has acquired GRAIL to accelerate patient access to multi cancer early detection test and gene sequencing procedures. This has helped the company to increase its product portfolio
